NLRP3 and major depressive disorder: NLRP3 inflammasome activation has been suggested a robust link to the onset and progression of a wide range of central nervous system (CNS) diseases, such as Alzheimer’s disease (AD) [20, 21], Parkinson’s disease (PD) [22–25], anxiety [26, 27], and MDD [27–30].